Roche grants Tamiflu sub-license to Hetero Drugs for India & developing countries

摘要

Roche has announced that it has granted a sub-license to Hyderabad-based,Hetero Drugs Ltd.for the production of oseltamivir (Tamiflu),as part of continued efforts to increase and speed up availability of the medicine for influenza pandemic planning world wide.The agreement with Hetero is focused on providing oseltamivir for government pandemic use and will have an immediate effect on the availability in India and developing countries - both directly and through further agreements with local companies.